|
?:authorAffiliation
|
-
[\'Cochrane France, Paris, France.\', \'Centre d\'Épidémiologie Clinique, AP-HP (Assistance Publique des Hôpitaux de Paris), Hôpital Hôtel Dieu, Paris, France.\', \'Université de Paris, Centre of Research in Epidemiology and Statistics (CRESS), INSERM, F-75004, Paris, France.\', \'Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany.\', \'Institute for Evidence in Medicine (for Cochrane Germany Foundation), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Cochrane Response, Cochrane, London, UK.\', \'Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.\', \'Open Patient data Explorative Network (OPEN), Odense University Hospital, Odense, Denmark.\', \'Epistemonikos Foundation, Santiago, Chile.\', \'HRB-Trials Methodology Research Network, National University of Ireland Galway, Galway, Ireland.\', \'Evidence Synthesis Ireland and Cochrane Ireland, Galway, Ireland.\', \'UC Evidence Center, Cochrane Chile Associated Center, Pontificia Universidad Católica de Chile, Santiago, Chile.\', \'Fondazione IRCCS Ca\' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.\', \'Department of Anesthesia, Intensive Care and Emergency, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.\', \'Department of Pathophysiology and Transplantation, Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}